Named as a key player in 33 of our reports, across 33 regions and countries.
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Biosimilars | Pharmaceuticals | $36.9 Bn | 24.9% |
Named as key players in the same markets as Shanghai Henlius Biotech (number of shared markets).
Amgen Inc.1 shared market
Biogen Inc1 shared market
Catalent1 shared market
Celltrion1 shared market
Novartis AG1 shared market
Patheon1 shared market
Pfizer Inc.1 shared market
Recent Developments1 shared market
Search all reports for Shanghai Henlius Biotech All companies